Popular Trials
Virus Vaccine
Shingles Vaccine for Lupus
This trial will compare the safety and effectiveness of a new shingles vaccine in people with lupus to a placebo vaccine. The study will last for 24 weeks and involve people of different ages and with different levels of lupus activity.
Popular Filters
Trials With No Placebo
RNA Vaccine
RNA Vaccine for Shingles
This trial is testing a new shingles vaccine called VZV modRNA in healthy people aged 50-69. The vaccine uses mRNA to help the body recognize and fight the virus that causes shingles. The study aims to see how safe the vaccine is and how well it works.
Virus Vaccine
Shingrix Vaccine Safety and Immunogenicity in People With HIV
This trial studies how the Shingrix vaccine affects people with HIV and healthy older adults. Shingrix helps prevent shingles by boosting the body's immunity against the virus. Participants will receive two shots and be monitored over time. Shingrix has shown promising results and is recommended for adults aged 50 and over.
Behavioral Intervention
Virtual Reality Therapy for Vertigo
This trial aims to see if the location of the inner ear problem affects how well virtual reality therapy works for patients. Fifty patients will be recruited from a neurotology clinic and split into two groups.
Cancer Vaccine
CRV-101 Vaccine for Shingles
This trial tests a new shingles vaccine called CRV-101 in adults aged 50 and older. The vaccine aims to boost the immune system to prevent shingles. Participants receive two injections and are monitored for safety and effectiveness.
Frequently Asked Questions
Introduction to shingles
What are the top hospitals conducting shingles research?
When it comes to clinical trials focused on shingles, several hospitals are making strides in research and treatment. Proactive Clinical Research, LLC in Fort Lauderdale is one such institution actively conducting a trial for this condition. While they do not yet have any completed shingles trials to their name, their dedication to finding solutions for patients with shingles is evident. In Honolulu, the East-West Medical Research Institute is also contributing to advancing knowledge about shingles through an ongoing clinical trial. With no previous trials conducted in this area either, their efforts show promise for future breakthroughs.
Centennial Medical Group located in Elkridge has joined the ranks of hospitals focusing on tackling the challenges of shingles through active clinical research as well. Like its counterparts mentioned above, Centennial Medical Group does not possess any prior experience with conducting shingles trials; however, their commitment signifies a continued effort within the medical community to explore new avenues of treatment and prevention.
Associates in Cardiology PA located in Silver Spring have similarly made strides by initiating an active clinical trial centered around shingles. As pioneers exploring this field further still lacks substantial groundwork which can be seen from absence of earlier attempts conducted by them or others alike.Their progress serves as a testament that even individualized healthcare practices play crucial roles when it comes to addressing unmet needs and pushing medical boundaries.
Finally Norfolk's Meridian Clinical Research joins these esteemed institutions with its own ongoing study dedicated solely towards understanding and combating against Shingle impact on lives.One may observe that like other smaller-scale facilities mentioned here ,they too lack elaborate history involving collection past accomplishments but regardless signifies that every step taken forward counts having profound implications waiting just around corner
Through these collective efforts across diverse locations throughout the United States—from sunny Florida all the way to tropical Hawaii—researchers are striving tirelessly toward improving our understanding of this painful viral infection known as shingles. Their dedication brings hope for those affected by providing opportunities for innovative treatments and potentially leading to the development of effective preventive measures.
Which are the best cities for shingles clinical trials?
When it comes to shingles clinical trials, several cities show promise in advancing research and treatment options. New york, New York leads the way with 6 active trials focused on studying SSA: Group 11 and other potential interventions. Columbus, Ohio follows closely behind with 3 ongoing studies examining similar treatments. Additionally, Stamford, Connecticut, Meridian, Idaho, and Rochester, New York each have 2 active trials investigating SSA: Group 11 and related approaches. These cities offer individuals affected by shingles access to cutting-edge clinical trials that may pave the path towards improved care and outcomes for this condition.
Which are the top treatments for shingles being explored in clinical trials?
When it comes to finding effective treatments for shingles, clinical trials have identified several promising options. Leading the pack is a drug known as Acyclovir, which has shown positive results in multiple studies. Another potential treatment being explored is Famciclovir, demonstrating its efficacy and safety profile in ongoing trials. Additionally, researchers are investigating the use of Valacyclovir as a potential therapy for shingles with encouraging outcomes thus far. These innovative treatments offer hope for individuals affected by this painful condition and may pave the way for improved management strategies in the future.
What are the most recent clinical trials for shingles?
Exciting progress is being made in the field of shingles research, with recent clinical trials offering new hope for those affected by this painful condition. One notable trial is SSA: Group 11, which has progressed to Phase 2 after an encouraging Phase 1. This study explores potential treatment options and their effectiveness against shingles. Additionally, another Phase 2 trial holds promise in evaluating a novel approach to combating shingles. With ongoing advancements in research and development, individuals suffering from this condition can anticipate improved outcomes and relief from the symptoms associated with shingles.
What shingles clinical trials were recently completed?
Recently completed clinical trials have made significant strides in the field of shingles research. Notably, a trial investigating a new vaccine candidate, sponsored by GlaxoSmithKline, concluded in June 2021. Another noteworthy completion was a trial exploring the efficacy of an antiviral medication called famciclovir, conducted by Novartis Pharmaceuticals and finalized in March 2021. These recent advancements highlight ongoing efforts to enhance prevention and treatment options for individuals affected by shingles and offer hope for better management of this painful condition.